legislature for PBM reform
Furthermore, the anti-inflammatory properties of GLP-1 agonists and their ability to enhance gut barrier integrity align with leading theories about IBS pathophysiology, suggesting a mechanistic basis for clinical improvement
Consult your clinician about the risks and benefits of any treatment
Compared to other GLP-1 receptor agonists like liraglutide (Saxenda, Victoza) or dulaglutide (Trulicity): It offers greater weight loss and blood sugar control benefits
Depending on the specific diagnosis, treatment approaches may include: therapeutic exercise chiropractic care anti-inflammatory strategies spinal decompression therapy targeted rehabilitation These approaches aim to reduce irritation of the affected nerve and improve spinal mechanics
Interest in GLP-based peptides continues to grow as scientists explore their potential roles in gastrointestinal physiology, endocrine communication, energy metabolism, and peptide receptor interactions